Rayence Co., Ltd.

Research Rayence Co., Ltd. (228850.KQ) on Bullrun: market cap KRW 131.56B, dividend yield 3.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 131.56B; dividend yield is 3.6%.

Peer valuation comparison

Latest dividend yield is 3.59% versus a Healthcare sector median of 2.4% (49.6% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 131.56Bn/a3.6%300

Dividend history

Latest trailing dividend snapshot: annual dividend/share 300 KRW, yield 3.6%.

About Rayence Co., Ltd.

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Rayence Co., Ltd.'s market cap?

Rayence Co., Ltd.'s market capitalization is KRW 131.56B.

Does Rayence Co., Ltd. pay a dividend?

Rayence Co., Ltd. has a dividend yield of 3.6%.

What does Rayence Co., Ltd. do?

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc.